Trial Profile
BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Osteoarthritis; Pain
- Focus Therapeutic Use
- Sponsors Allergan
- 01 Oct 2019 Primary endpoint (Change from Baseline in the 7-Day Average Daily Pain Score Using an 11-Point Scale) has been met.
- 11 Jul 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 The trial was completed in Czech Republic (end date: 07-03-2016).